Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of Bifidobacterium Quadruple Live Bacteria Powder in children with functional constipation
CTR20250954Phase 2Active
- Sponsor
- Hangzhou Grand Biologic Pharmaceutical Inc.
- Start
- Mar 2025
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of bifidobacterium quadruple live bacteria powder in functional constipation (FC), sponsored by Hangzhou Grand Biologic Pharmaceutical Inc.. Started Mar 2025; status: active.
02
Drugs
bifidobacterium quadruple live bacteria powder
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on CTR20250954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250954.